Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jan Hoinka"'
Autor:
Sophie Papa, James Spicer, Debra H Josephs, Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, Robert Page, Ashley Di Meo, Silvia Mele, Giulia Chiaruttini, Jan Hoinka, Ihor Batruch, Ioannis Prassas, Melanie Grandits, Jacobo López-Abente, Eva Bugallo-Blanco, Malcolm Ward, Heather J Bax, Elise French, Anthony Cheung, Sara Lombardi, Mariangela Figini, Katie E Lacy, Eleftherios P Diamandis, Sophia N Karagiannis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Cancer immunotherapy with monoclonal antibodies and chimeric antigen receptor (CAR) T cell therapies can benefit from selection of new targets with high levels of tumor specificity and from early assessments of efficacy and safety to deris
Externí odkaz:
https://doaj.org/article/836d29985b964cc8b16ff8085298d717
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 11, Iss C, Pp 515-517 (2018)
Externí odkaz:
https://doaj.org/article/e1c3f59cdf34462d9da04a25bc1937c0
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
Externí odkaz:
https://doaj.org/article/10fd125671564bd294abbbe7f2a0a467
Autor:
Jan Hoinka, Teresa M. Przytycka
Publikováno v:
Methods in Molecular Biology ISBN: 9781071626948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef4b9cc9cc7fc2971f52b92a0ddd33d4
https://doi.org/10.1007/978-1-0716-2695-5_6
https://doi.org/10.1007/978-1-0716-2695-5_6
Autor:
Jan, Hoinka, Teresa M, Przytycka
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2570
Next-generation systematic evolution of ligands by exponential enrichment approaches consistently combine the experimental protocol with high-throughput sequencing after each round of selection. This extension, known as HT-SELEX, results in a vast am
Publikováno v:
Journal of Computational Biology
The AptaBlocks Web Interface is focused on providing graphical, intuitive, and platform-independent access to AptaBlocks, an experimentally validated algorithmic approach for the in silico design of oligonucleotide sticky bridges. The availability of
Autor:
Jacobo López-Abente, Sophie Papa, Ioannis Prassas, Silvia Crescioli, Eleftherios P. Diamandis, Heather J. Bax, Robert Page, Olivier Martinez, James Spicer, Silvia Mele, Jan Hoinka, Ashley Di Meo, Debra H. Josephs, Sara Lombardi, Giulia Pellizzari, Mariangela Figini, Elise French, Melanie Grandits, Giulia Chiaruttini, Sophia N. Karagiannis, Anthony Cheung, Ihor Batruch, Katie E. Lacy, Eva Bugallo-Blanco, Malcolm Ward
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundCancer immunotherapy with monoclonal antibodies and chimeric antigen receptor (CAR) T cell therapies can benefit from selection of new targets with high levels of tumor specificity and from early assessments of efficacy and safety to derisk
Autor:
Agnivo Gosai, Charith Geekiyanage, Teresa M. Przytycka, Natalie Ruggio, Marit Nilsen-Hamilton, Shambhavi Shubham, Pranav Shrotriya, Soma Banerjee, Zhichen Zhu, Wendy Maury, Jake Dillard, Sivaranjani Devarakonda, Jan Hoinka, Nicholas J. Lennemann
Publikováno v:
The FASEB Journal. 35
Publikováno v:
Cell systems. 12(10)
Many mutagenic processes leave characteristic imprints on cancer genomes known as mutational signatures. These signatures have been of recent interest regarding their applicability in studying processes shaping the mutational landscape of cancer. In
Autor:
Nicolas A Abrigo, Matthew C. T. Hartman, David E. Hacker, Jan Hoinka, Stacie L. Richardson, Teresa M. Przytycka
Publikováno v:
ACS Comb Sci
[Image: see text] Peptide macrocyclization is typically associated with the development of higher affinity and more protease stable protein ligands, and, as such, is an important tool in peptide drug discovery. Yet, within the context of a diverse li